SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000898430-97-005209
Filing Date
1997-12-08
Accepted
1997-12-08 00:00:00
Documents
3
Group Members
BIOTECHNOLOGY VALUE FUND L P ET ALBVF PARTNERS, L.P.BVF, INC.
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D SC 13D/A 17245
2 AGREEMENT REGARDING JOINT FILING EX-99.A 1366
3 TRANSACTIONS IN THE STOCK BY REPORTING PERSONS EX-99.B 9542
  Complete submission text file 0000898430-97-005209.txt   30517
Mailing Address 385 OYSTER POINT BLVD SUITE 3 SOUTH SAN FRANCISCO CA 94080
Business Address 180 KIMBALL WAY SOUTH SAN FRANCISCO CA 94080 4157378600
ARRIS PHARMACEUTICAL CORP/DE/ (Subject) CIK: 0000913056 (see all company filings)

IRS No.: 222969941 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44967 | Film No.: 97734102
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET 39TH FLOOR SAN FRANCISCO CA 94104 415-288-2395
BIOTECHNOLOGY VALUE FUND L P ET AL (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice